secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2026-04-01T23:59:59+00:00
Accession:  0001493152-26-014676
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air CEO Steve Lisi resigns; Robert Goodman appointed CEO effective March 27, 2026
--------------------------------------------------------------------------------

- Steve Lisi resigned as CEO and director, effective March 27, 2026; no disagreement with the Company.
- Robert Goodman, previously Chief Commercial Officer and director, appointed CEO effective March 27, 2026.
- Lisi receives $650,000 severance over 12 months, 12 months of COBRA premiums, and accelerated vesting of all unvested equity.
- Goodman has 25+ years in healthcare sales leadership; prior roles include BioTelemetry, Philips, Cardiocore, Thermo Fisher, and Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226014676/0001493152-26-014676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226014676/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-014676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer